Xiunis

Xiunis (Rezafungin Acetate) is an antifungal medication for intravenous use, designed to target serious fungal infections. This EU-sourced treatment supports infection management with targeted therapy. Suitable for patients requiring systemic antifungal support. Always consult a healthcare provider for personalized advice.

Xiunis (Rezafungin Acetate) is used to treat serious fungal infections, including invasive candidiasis and other systemic mycoses. It works by targeting fungal cell walls to reduce infection spread. Commonly prescribed when other antifungals are ineffective or unsuitable. Often used in hospital settings for severe cases.

Xiunis may help reduce symptoms of fungal infections such as fever, chills, and inflammation. Patients may experience improved clinical signs as the medication works systemically. Individual responses vary based on infection type and severity. Regular monitoring is recommended during treatment.

Store Xiunis as directed by healthcare professionals, typically at controlled room temperature. Protect from light and moisture. Only administer under medical supervision in a clinical setting. Ensure proper handling to maintain sterility and efficacy.

Xiunis may interact with other medications affecting liver enzymes, such as certain antifungals or immunosuppressants. Caution is advised when combining with drugs metabolized by CYP enzymes. Alcohol use should be avoided during treatment. Always disclose all medications to your healthcare provider.